首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1452798

全球 RNA 分析市場規模、佔有率、成長分析（按技術、按產品、按應用）- 產業預測 (2024-2031)

Global RNA Analysis Market Size, Share, Growth Analysis, By Technology(Real Time-PCR Technology, Microarray Technology), By Product, By Application - Industry Forecast 2024-2031

出版日期: 2024年03月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球RNA分析市場規模為155億美元，從2023年的161.2億美元成長到2031年的220.6億美元，年複合成長率預計為4.00%。

由於越來越多的人採用礦物質補充品來治療大部分人群中普遍存在的慢性疾病，例如癌症、骨質疏鬆症和貧血症，這個市場正在蓬勃發展。大型製藥公司積極參與社會宣傳活動，以促進更健康的生活方式和補充品的使用。例如，2023 年 2 月，Torrent Pharmaceuticals Ltd 推出了#BeShelcalStrong，這是一項電視宣傳活動，旨在提高人們對缺乏鈣及其對日常生活影響的認知。隨著久坐生活方式和不健康飲食的增加，越來越多的人面臨營養缺乏，導致疲勞、骨骼脆弱和免疫系統減弱等問題。政府促進健康生活方式的措施進一步促進了市場成長。主要參與者專注於創新產品開發和探索異國風成分，而植物來源產品的流行提供了進一步的成長機會。在 COVID-19 大流行期間，對礦物質補充食品的需求增加，因為研究表明該病毒對礦物質缺乏症的影響尤其嚴重。儘管有這些積極的趨勢，但市場仍面臨仿冒品銷售的挑戰，因為經濟危機和政治衝突擾亂了供應鏈並導致更便宜的本地生產商品的擴散。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Thermo Fisher Scientific Inc.（USA）
Illumina, Inc.（USA）
Agilent Technologies, Inc.（USA）
Qiagen AG（Germany）
PerkinElmer, Inc.（USA）
Eurofins Scientific SE（Luxembourg）
Genewiz（a Brooks Life Sciences Company）（USA）
Bio-Rad Laboratories, Inc.（USA）
Merck KGaA（Germany）
Promega Corporation（USA）
Fluidigm Corporation（USA）
Oxford Nanopore Technologies Ltd.（United Kingdom）
Takara Bio Inc.（Japan）
Zymo Research Corporation（USA）
BGI Group（China）
NuGEN Technologies, Inc.（USA）
Lexogen GmbH（Austria）
Pacific Biosciences of California, Inc.（USA）
Roche Diagnostics（Switzerland）
Bio-Techne Corporation（USA）

簡介目錄

Product Code: SQMIG35H2192

Global RNA Analysis Market size was valued at USD 15.5 billion in 2022 and is poised to grow from USD 16.12 billion in 2023 to USD 22.06 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

The market is experiencing a surge driven by the growing adoption of mineral supplements to manage chronic conditions prevalent in a significant portion of the population, such as cancer, osteoporosis, anemia, and osteoporosis. Major pharmaceutical companies are actively engaging in social campaigns to promote healthier lifestyles and supplement usage. For instance, in February 2023, Torrent Pharmaceuticals Ltd launched the TV campaign #BeShelcalStrong, aiming to raise awareness about calcium deficiency and its impact on daily life. The rise in sedentary lifestyles and unhealthy diets has resulted in more people facing nutritional deficiencies, leading to issues like fatigue, weak bones, and compromised immune systems. Government initiatives promoting healthier lifestyles further contribute to market growth. Key players are focusing on innovative product development and exploring exotic ingredients, while the popularity of plant-based products presents additional growth opportunities. Amid the COVID-19 pandemic, mineral supplements witnessed increased demand, as research indicated the virus disproportionately affected individuals with mineral deficiencies. Despite this positive trend, the market faces challenges from counterfeit product sales, driven by economic crises and political conflicts disrupting the supply chain and leading to the proliferation of locally produced, inexpensive items.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global RNA Analysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global RNA Analysis Market Segmental Analysis

The global RNA analysis market is segmented on the basis of technology, product, application, end - use, region. By technology, the market is segmented real time-pcr (QPCR) technology, microarray technology, sequencing technology, and others. By product, the market is segmented into instruments, kits & reagents, cho media mirna & sirna, reverse transcriptases & rt-pcr, rna interference, rna extraction & purification, others, services. By application, the market is segmented into construction of rna expression atlas, infectious diseases & pathogenesis, epigenetics, alternative rna splicing, rna structure & molecular dynamics, development & delivery of rna therapeutics, others. By end - use, the market is segmented into government institutes & academic centers, contract research organizations (CROs), pharmaceutical & biotechnology companies, hospitals & clinics. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global RNA Analysis Market

The pharmaceutical and biotech industries extensively depend on RNA analysis for the advancement of targeted therapies, personalized medicine, and novel drug candidates. This heightened reliance has generated significant demand for RNA analysis techniques within these sectors.

Restraints in the Global RNA Analysis Market

Analyzing RNA sequencing data requires intricate bioinformatics expertise and resources, posing a potential barrier to its widespread adoption in certain environments. The complexity of the process may limit accessibility and implementation in settings where specialized skills and dedicated resources may be scarce.

Market Trends of the Global RNA Analysis Market

The progress in long-read sequencing technologies has empowered the precise sequencing of entire RNA molecules, thereby advancing our comprehension of alternative splicing, isoforms, and intricate gene structures.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global RNA Analysis Market by Technology

Market Overview
Real Time-PCR (qPCR) Technology
Microarray Technology
Sequencing Technology
Others

Global RNA Analysis Market by Product

Market Overview
Instruments
Kits & Reagents
CHO Media miRNA & siRNA
Reverse Transcriptases & RT-PCR
RNA Extraction & Purification
RNA Interference
Others
Services

Global RNA Analysis Market by Application

Market Overview
Construction of RNA Expression Atlas
Epigenetics
Infectious Diseases & Pathogenesis
Alternative RNA Splicing
RNA Structure & Molecular Dynamics
Development & Delivery of RNA Therapeutics
Others

Global RNA Analysis Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz (a Brooks Life Sciences Company) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zymo Research Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuGEN Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lexogen GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments